By transforming human scar cells into blood vessel cells, scientists at Houston Methodist may have discovered a new way to repair damaged tissue.
The method, described in an upcoming issue of Circulation (early online), appeared to improve blood flow, oxygenation, and nutrition to areas in need.
Cardiovascular scientists at Houston Methodist, with colleagues at Stanford University and Cincinnati Children’s Hospital, learned that fibroblasts — cells that causes scarring and are plentiful throughout the human body — can be coaxed into becoming endothelium, an entirely different type of adult cell that forms the lining of blood vessels.
“To our knowledge, this is the first time that trans-differentiation to a therapeutic cell type has been accomplished with a small molecules and proteins,” said Houston Methodist Research Institute Department of Cardiovascular Sciences Chair John Cooke, M.D., Ph.D., the study’s principal investigator. “In this particular case, we’ve found a way to turn fibroblasts into ‘shapeshifters’ nearly on command.”
Cooke said the regenerative medicine approach provides proof-of-concept for a small molecule therapy that could one day be used to improve the healing of cardiovascular damage or other injuries.
Other research groups have managed to generate endothelial cells cells using infectious virus particles specially engineered to deliver gene-manipulating DNA to cells. The DNA encodes proteins called transcription factors to alter gene expression patterns in such a way that cells behave more like endothelial cells.
“There are problems with using viruses to transfer genes into cells,” Cooke said. “This gene therapy approach is more complicated, and using viral vectors means the possibility of causing damage to the patient’s chromosomes. We believe a small-molecule approach to transforming the cells will be far more feasible and safer for clinical therapies.”
The Latest on: Reprogrammed cells
[google_news title=”” keyword=”Reprogrammed cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Reprogrammed cells
- How aging clocks tick: New study points to stochastic changes in cellson May 9, 2024 at 7:13 am
Aging clocks can measure the biological age of humans with high precision. Biological age can be influenced by environmental factors such as smoking or diet, thus deviating from chronological age that ...
- Breakthrough by Shanghai doctors uses stem cells to cure diabeteson May 8, 2024 at 6:24 pm
Doctors in Shanghai have, for the first time in the world, cured a patient's diabetes through the transplantation of pancreatic cells derived from stem cells. The 59-year-old man, who had Type 2 ...
- €2.6 Million Funding Boosts Ground-breaking CAR T Cell Therapy Study in Advanced Lymphomason May 7, 2024 at 8:30 am
Million Funding Boosts Ground-breaking CAR T Cell Therapy Study in Advanced Lymphomas Dr. Kerstin Wild Stabsstelle „Strategische Entwicklung“ Leibniz ...
- New mRNA cancer vaccine helps immune system fight deadly brain tumorson May 7, 2024 at 8:23 am
Researchers from the University of Florida have developed a new mRNA cancer vaccine to retrain the body's immune system to attack and potentially treat glioblastoma, a deadly form of brain cancer.
- Precision medicine tool predicts breast cancer immunotherapy responseon May 6, 2024 at 10:30 am
New InteractPrint tool analyzes how breast cancer epithelial cells impact cancer-immune interactions, enabling prediction of immune checkpoint inhibition response.
- OverT Bio Raises $16 Million, Tapping Innovative Reprogramming of Immune Cells to Deliver Next-Generation Therapieson May 6, 2024 at 6:59 am
OverT Bio, a data-driven company working to unlock the curative potential of cell therapies in solid tumors, announced today that it has raised $16 million in seed funding. The round was co-led by ...
- Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024on May 6, 2024 at 1:00 am
May 06, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors ...
- Engineering Life: Chemists Have Created the Functional Synthetic Cells That Act Like Real Oneson May 3, 2024 at 6:10 pm
Researchers employ cutting-edge methods to create functional cells, closing the divide between synthetic and biological materials. In a new study published in Nature Chemistry, UNC-Chapel Hill researc ...
- How cancer cells harness energy to drive disease progressionon May 3, 2024 at 11:11 am
Researchers have revealed crucial insights into how the Warburg effect causes the dedifferentiation of cancer cells through epigenetic reprogramming. This discovery potentially opens up new avenues ...
- Revealed: How cancer cells harness energy to drive disease progressionon May 2, 2024 at 5:00 pm
Researchers have revealed crucial insights into how the Warburg effect causes the dedifferentiation of cancer cells through epigenetic reprogramming.
via Bing News